Skip to main content
OpenTrials

Clinical trial condition

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Explore clinical trials studying Precursor Cell Lymphoblastic Leukemia-Lymphoma. Study availability and eligibility vary by location and protocol.

1,816 public trials 304 recruiting studies
Refine in advanced search Browse all conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma trial results

Recruiting

A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia

NCT04307576

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • L'hôpital Universitaire des enfants Reine Fabiola (Huderf) Brussels, Belgium
  • Cliniques Universitaires Saint-Luc (UCL) Brussels, Belgium
  • University Hospital Antwerp Edegem, Belgium
  • University Hospital Ghent Ghent, Belgium
View all 137 locations
View Trial Details
Recruiting

Determining the Mechanisms of Loss of CAR T Cell Persistence

NCT05809284

Conditions
Acute Lymphoblastic Leukemia Not Having Achieved Remission, Acute Lymphoblastic Leukemia With Failed Remission, Acute Lymphoblastic Leukemia, Adult, +13 more
Locations
  • Great Ormond Street Hospital London, United Kingdom
  • University College London Hospital London, United Kingdom
  • Royal Manchester Children's Hospital Manchester, United Kingdom
View Trial Details
Recruiting

GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of Adult Acute Lymphoblastic Leukemia (ALL) Patients and Related Diseases Associated With a Prospective Collection of Biomaterial

NCT02872987

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
Locations
  • Universitätsklinikum Graz Graz, Austria
  • LKH-Hochsteiermark Leoben Leoben, Austria
  • Hanusch-Krankenhaus Wien Vienna, Austria
  • University Hospital of Frankfurt (Main) Frankfurt am Main, Hesse, Germany
View all 147 locations
View Trial Details
Recruiting

225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome

NCT06287944

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +15 more
Locations
  • City of Hope Medical Center Duarte, California, United States
View Trial Details

Related conditions